{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal placental",
            "NStudiesAvail": 430108,
            "NStudiesFound": 26,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 26,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "The rate of serious adverse event in 1 hour after single dose of Human placental mesenchymal stem cells gel on Human diabetic food ulcer.",
                              "Rate of cure rate in 20 days and 34 days after multi-dose of Human placental mesenchymal stem cells gel on Human diabetic food ulcer."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Rate of serious adverse event",
                              "Rate of cure rate"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "0 hour - 1 hour",
                              "0 day - 34 days"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04464213"
                        ]
                  },
                  {
                        "Rank": 2,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "To evaluate if there have occured the adverse everts such as fever, allergy, et al. and their severity."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "To evaluate the incidence and severity of adverse events of transplantation treatment using umbilical cord/placenta-derived mesenchymal stem cells in patients with type 2 diabetes mellitus"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "1 year"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01413035"
                        ]
                  },
                  {
                        "Rank": 3,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [],
                        "SecondaryOutcomeTimeFrame": [],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT05499156"
                        ]
                  },
                  {
                        "Rank": 4,
                        "ResultsFirstSubmitDate": [
                              "October 20, 2015"
                        ],
                        "ResultsFirstSubmitQCDate": [
                              "November 24, 2015"
                        ],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Forced Vital Capacity (FVC) was measured and reported as a percentage of predicted and comapred from 6 months post-infusion to baseline",
                              "At 6 months 6 Minute Walk Distance was mesured and compared as a percentage to baseline",
                              "DLCO was measured as a percentage of predicted, and the percentage change between 6 months post-infusion and baseline is reported."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Percentage Change in Lung Function as Assessed by FVC Compared to Baseline",
                              "Percentage Change in 6 Minute Walk Distance Compared to Baseline",
                              "Percentage Change in Lung Function as Assessed by DLCO Compared to Baseline"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "6 months post MSC infusion",
                              "Baseline and 6 months post MSC infusion",
                              "6 months post MSC infusion"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [
                              "Non-systematic Assessment"
                        ],
                        "NCTId": [
                              "NCT01385644"
                        ]
                  },
                  {
                        "Rank": 5,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [],
                        "SecondaryOutcomeTimeFrame": [],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT05402748"
                        ]
                  },
                  {
                        "Rank": 6,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "End Diastolic Velocity without trimix (cm/s)",
                              "End Diastolic Velocity without trimix (cm/s)",
                              "End Diastolic Velocity without trimix (cm/s)",
                              "End Diastolic Velocity without trimix (cm/s)",
                              "End Diastolic Velocity without trimix (cm/s)"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Baseline",
                              "6 weeks",
                              "3 months",
                              "6 months",
                              "12 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02395029"
                        ]
                  },
                  {
                        "Rank": 7,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "End Diastolic Velocity without trimix (cm/s)",
                              "End Diastolic Velocity without trimix (cm/s)",
                              "End Diastolic Velocity without trimix (cm/s)",
                              "End Diastolic Velocity without trimix (cm/s)",
                              "End Diastolic Velocity without trimix (cm/s)"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Baseline",
                              "6 weeks",
                              "3 months",
                              "6 months",
                              "12 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02398370"
                        ]
                  },
                  {
                        "Rank": 8,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Change in joint function from baseline WOMAC assessment. The WOMAC used a scoring scale of 0-4 (lower scores indicate lower levels of symptoms or physical disability). The higher the score, the higher the amount of pain, stiffness, and a high level of functional limitations.",
                              "Change in cartilage thickness of the knee using MRI",
                              "Change in scores on the QOL",
                              "VAS - measure of pain intensity. The scale is most commonly anchored by \"no pain \" (score of 0) and \"worst imaginable pain\" (score of 10)."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Physical function improvement measured by Western Ontario and McMaster Universities Arthritis Index (WOMAC).",
                              "Radiographic evidence. Whole-Organ Magnetic Resonance Imaging Score (WORMS)",
                              "Quality of Life (QOL) assessment",
                              "The Visual Analog Scale (VAS) assessment"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "12 months.",
                              "12 months",
                              "12 months",
                              "12 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04453111"
                        ]
                  },
                  {
                        "Rank": 9,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "This is primarily evaluated by improvement in motor function 2 or more levels greater than expected by anatomic level of the defect and by patients' ability to walk independently. Bowel function will be assessed by caregiver questionnaires on bowel habits, and by anorectal manometry. Urologic function will be assessed by caregiver questionnaires regarding urologic function, by renal and bladder ultrasounds to evaluate for hydronephrosis and bladder abnormalities, and by video urodynamics."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Efficacy of the PMSC-ECM Product"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "30 months."
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04652908"
                        ]
                  },
                  {
                        "Rank": 10,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Percentages of T regulatory cell population in peripheral blood will be tested in every 3 months after transplanting MSCs for one year",
                              "Side effects were observed after the treatment"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Percentage of systemic T regulatory cell population",
                              "Side effects"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "1 year",
                              "1 year"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01420432"
                        ]
                  },
                  {
                        "Rank": 11,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [
                              "No. 30670903"
                        ],
                        "SecondaryIdDomain": [
                              "National Natural Science Foundation of China"
                        ],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [
                              "Other Identifier"
                        ],
                        "SecondaryOutcomeDescription": [
                              "Percentages of T regulatory cell population and T lymphocyte subsets in peripheral blood will be tested in every 3 months after transplanting MSCs for one year."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Percentage of systemic T regulatory cell population and T lymphocyte subsets"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "1 year"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01182662"
                        ]
                  },
                  {
                        "Rank": 12,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [
                              "No. 30670903"
                        ],
                        "SecondaryIdDomain": [
                              "National Natural Science Foundation of China"
                        ],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [
                              "Other Identifier"
                        ],
                        "SecondaryOutcomeDescription": [
                              "Percentage of T regulatory cell population in peripheral blood will be tested in every 3 months after transplanting MSCs for one year."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Percentage of T regulatory cell population in peripheral blood"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "1 year"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01129739"
                        ]
                  },
                  {
                        "Rank": 13,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Number of participants with a change in cartilage thickness of knee OA using MRI",
                              "Number of participants with a change in joint function from baseline WOMAC assessment",
                              "Number of participants with a change in arthritis pain scores on the visual analogue scale",
                              "Number of participants with a change in SF-36"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "radiographic evidence",
                              "WOMAC assessment",
                              "VAS",
                              "SF-36"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "1 Year",
                              "1 Year",
                              "1 Year",
                              "1 Year"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03028428"
                        ]
                  },
                  {
                        "Rank": 14,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "The following information will be collected from the subjects during the follow-up visits or calls:\n\nMedical history review\nPhysical exam and vital signs\nAssessment for delayed adverse reactions",
                              "Survival of the subjects in the 2 arms of the study",
                              "COVID-19 polymerase chain reaction (PCR) test result as negative in the subjects in the 2 arms of the study"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Time to clinical improvement",
                              "Overall Survival",
                              "COVID-19 polymerase chain reaction (PCR) test result as negative"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "3 months",
                              "3 months",
                              "3 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT05387278"
                        ]
                  },
                  {
                        "Rank": 15,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Infection biomarker. Serum CRP levels can be used for early diagnosis of pneumonia, patients with severe pneumonia had high CRP levels.",
                              "CT assessment of pulmonary lesions and lung tissue changes",
                              "Indirect response to lung function",
                              "Degree of infection"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Changes of \u0421-reactive protein (CRP, mg/L)",
                              "Evaluation of Pneumonia Improvement",
                              "Duration of respiratory symptoms (difficulty breathing, dry cough, fever, etc.)",
                              "Peripheral blood count recovery time"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8",
                              "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8",
                              "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8",
                              "At baseline, Day 1, Week 1, Week 2, Week 4, Week 8"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04461925"
                        ]
                  },
                  {
                        "Rank": 16,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [
                              "Non-Probability Sample"
                        ],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Relationship between in vivo and in vitro mitochondrial capacity will be measured with in vivo mitochondrial capacity measured by 31P-MRS and infant in vitro mitochondrial capacity measured by oxygen consumption rates in umbilical cord derived mesenchymal stem cells",
                              "Relationship between in vivo and in vitro mitochondrial capacity will be measured with in vivo mitochondrial capacity measured by 31P-MRS and maternal in vitro mitochondrial capacity measured by oxygen consumption rates in maternal primary myotubes"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Relationship between in vivo mitochondrial capacity and infant in vitro mitochondrial capacity (by oxygen consumption rates)",
                              "Relationship between in vivo mitochondrial capacity and maternal in vitro mitochondrial capacity (by oxygen consumption rate)"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "About 20 weeks",
                              "About 15 weeks"
                        ],
                        "SeeAlsoLinkLabel": [
                              "Pennington Biomedical Research Center website description and webscreener survey"
                        ],
                        "SeeAlsoLinkURL": [
                              "http://www.pbrc.edu/clinical-trials/?studyid=260"
                        ],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03489564"
                        ]
                  },
                  {
                        "Rank": 17,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [],
                        "SecondaryOutcomeTimeFrame": [],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03337243"
                        ]
                  },
                  {
                        "Rank": 18,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "Tumorigenesis"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "24 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT00919958"
                        ]
                  },
                  {
                        "Rank": 19,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [],
                        "SecondaryOutcomeTimeFrame": [],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT00749164"
                        ]
                  },
                  {
                        "Rank": 20,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [],
                        "SecondaryOutcomeTimeFrame": [],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT00951210"
                        ]
                  },
                  {
                        "Rank": 21,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "All-cause mortality",
                              "Duration of mechanical ventilation"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "28 and 60 days",
                              "28 and 60 days"
                        ],
                        "SeeAlsoLinkLabel": [
                              "Related Info"
                        ],
                        "SeeAlsoLinkURL": [
                              "http://www.pluristem.com"
                        ],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04614025"
                        ]
                  },
                  {
                        "Rank": 22,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Change in maximum level of dyspnea experienced during the six minute walk test using a 10 point scale.",
                              "Change in RV area at end systole and end diastole (for calculation of estimated RV ejection fraction, RV basal and mid diameter at end systole and end diastole, RV free wall thickness, tricuspid annular plane systolic excursion (TAPSE), maximal tricuspid regurgitant jet velocity TRJV) and pulmonary artery end diastolic pressure (PAEDP)",
                              "mean pulmonary arterial pressure (PAPm), heart rate (HR), systolic systemic arterial pressure (SAPs), diastolic systemic arterial pressure (SAPd), mean systemic arterial pressure (SAPm), pulmonary artery systolic pressure (PAPs), pulmonary artery diastolic pressure (PAPd), mean right atrial pressure (RAPm), mean pulmonary capillary wedge pressure (PCWPm), and cardiac output (CO)"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Change in Six Minute Walk distance",
                              "Change in Dyspnea Score",
                              "Change in WHO Functional Classification",
                              "Change in Plasma NT-pro-BNP levels",
                              "Change from Baseline in echocardiography parameters",
                              "Change in cardiopulmonary hemodynamics"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Baseline and 6 weeks",
                              "Baseline and 6 weeks",
                              "Baseline and 6 weeks",
                              "Baseline and 6 weeks",
                              "Baseline and 6 weeks",
                              "Baseline and 6 weeks"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01795950"
                        ]
                  },
                  {
                        "Rank": 23,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [],
                        "SecondaryOutcomeMeasure": [
                              "All-cause mortality",
                              "Duration of mechanical ventilation"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "28 days",
                              "8 weeks"
                        ],
                        "SeeAlsoLinkLabel": [
                              "Related Info"
                        ],
                        "SeeAlsoLinkURL": [
                              "http://www.pluristem.com"
                        ],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04389450"
                        ]
                  },
                  {
                        "Rank": 24,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Death prior to discharge from initial hospitalization",
                              "1 year (12 - 16 postnatal months) Bayley Scales of Infant and Toddler Development, Third Edition (Bayley III) assessments in cognitive, language and motor development. Moderate to Severe CP will be assigned with cognitive score ,70, motor score ,70 and with Gross Motor Function Classification System >=2."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Survival",
                              "Neurodevelopmental Assessments"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Up to 6 months",
                              "Up to 16 postnatal months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT03635450"
                        ]
                  },
                  {
                        "Rank": 25,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [
                              "Probability Sample"
                        ],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Assessed during a standard infant formula test as the difference in RQ between the postprandial and the fasting period via indirect calorimetry.",
                              "Lipid content will be measured in placenta samples via immunohistochemistry antibody staining for lipid droplet proteins and by Oil Red O staining.",
                              "Oxygen consumption rates of isolated mitochondria from placenta will be measured by the SeaHorse device.",
                              "Mesenchymal stem cells will be differentiated to a myogenic state and assessed for lipid content via Oil Red O staining",
                              "Mesenchymal stem cells will be differentiated to a myogenic state and assessed for oxygen consumption rates using the Oroboros device."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Metabolic Flexibility - Infant",
                              "Lipid content in placenta samples",
                              "Mitochondrial oxygen consumption rates in placenta samples",
                              "Fat content in umbilical cord mesenchymal stem cells",
                              "Oxygen consumption rates in umbilical cord mesenchymal stem cells"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "One day",
                              "One day (delivery)",
                              "One day (delivery)",
                              "One day (delivery)",
                              "One day (delivery)"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT02926079"
                        ]
                  },
                  {
                        "Rank": 26,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Doppler study of the endometrial blood flow; the VI, FI and VFI and 3D-US assessment of endometrial volume in all groups at the day of embryo transfer to obtain objective assessment of the effect of differentiated and undifferentiated stem cell therapy on endometrial volume and vascularity in ICSI patients with advanced maternal age or history of repeated implantation failure."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Endometrial volume and vascularity"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "6 months"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT01649752"
                        ]
                  }
            ]
      }
}